Share on:
Arcam received an order for five Arcam Q10 systems from Beijing AK Medical, a present customer in China. The systems will be used for volume production of orthopaedic implants.
Beijing AK Medical, an Arcam customer since 2010, announced in August its formal approval from the Chinese State Food and Drug Administration (CFDA) for EBM-manufactured implants. This was the first CFDA marketing approval for an additively manufactured orthopaedic implant.
Arcam Group provides Additive Manufacturing solutions for the production of metal components.
RELATED ARTICLES
Janco Medical to Focus on Packaging and Cleanroom Manufacturing
Apr 10 2024 , Julie A. Vetalice
Evonik Grows Capacity for Customized RESOMER Powder Biomaterials
Apr 10 2024 , Julie A. Vetalice
Exploring Why Automation Leads to Improved Medical Device Manufacturing
Apr 09 2024 , Lowell
FDA De Novo for Orthobond’s Ostaguard Antibacterial Surface Treatment
Apr 08 2024 , Julie A. Vetalice